Back to results
US 2021/0276996 A1Published application
Degraders that target proteins via keap1
AssigneeDana-Farber Cancer Institute, Inc.
InventorsNathanael S. Gray, Tinghu Zhang, Eric Fischer, Guangyan Du, Nozhat Safaee, Nathaniel Henning, Katherine Donovan
Life of this patent
Estimating the term…
Abstract
Disclosed are bifunctional compounds, pharmaceutical compositions containing them, and methods of making and using them to treat diseases and disorders characterized by aberrant protein activity wherein the protein is targeted for degradation by KEAP1 and the Cul3-based E3-ubiquitin ligase complex.
Claims17
A bifunctional compound having a structure represented by formula (I):
- wherein:
- R is methyl or halo;
- R1 is
- R2 is methyl,
- wherein L is a linker and TL is a targeting ligand that binds a protein of interest, or
- wherein
- R3 is H or
- R4 is H, halo or
- R5 is methoxy or
- R6 is H or methyl;
- and
- R8 is H or ethyl;
- provided that one of R2, R3, R4 and R5 is
- or a pharmaceutically acceptable salt or stereoisomer thereof.
11 more elements
Dependencies are inferred from the claim text.